ArticleACS omega2022
Cu-Doped 1D Hydroxyapatite as a Highly Active Catalyst for the Removal of 4-Nitrophenol and Dyes from Water.
Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 46 citations in OpenAlex.
- Nickel nanoparticles supported by fishbone-derived hydroxyapatite as a bifunctional catalyst for 4-nitrophenol reduction and methanation of carbon oxides.RSC advances · 2026Article
- Multifunctional porous ag/biocomposite: synthesis, catalytic reduction ofRSC advances · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metallic copper nanoparticle (Cu NP)-doped 1D hydroxyapatite was synthesized using a simple chemical reduction method. To describe the structure and composition of the Cu/HAP nanocomposites, physicochemical techniques such as X-ray diffraction, Fourier transform infrared spectroscopy, inductively coupled plasma, N
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.